Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000929673 | SCV001075308 | likely benign | not provided | 2018-06-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004029554 | SCV004873408 | uncertain significance | not specified | 2024-01-16 | criteria provided, single submitter | clinical testing | The c.2578G>A (p.D860N) alteration is located in exon 5 (coding exon 3) of the AHNAK gene. This alteration results from a G to A substitution at nucleotide position 2578, causing the aspartic acid (D) at amino acid position 860 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV000929673 | SCV005224424 | likely benign | not provided | criteria provided, single submitter | not provided |